Dedicated to finding a
cure for brain cancer
Emerging Leader Grant Award
The Ben & Catherine Ivy Foundation Emerging Leader Award provides grant support to early-to-mid-career investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support ambitious pilot projects designed to identify drug strategies appropriate for early-phase pharmacodynamic- and pharmacokinetic-driven clinical trials in partnership with the Ivy Brain Tumor Center.
Translational Adult Glioma Award
The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.
We strive to improve the quality of life and increase the life expectancy of people diagnosed with brain cancer by funding promising research that creates more diagnostics and treatments for patients.
- Stem Cells
Brain cancer completely turned John Barrows’ world upside down but The Ben and Catherine Ivy Foundation’s partnership with Dr. Greg Foltz led to progress in finding a cure for this devastating disease.
Introducing the Largest Phase 0 Clinical Trials Program in the World
Sanjiv Sam Gambhir M.D., Ph.D
Ivy Foundation Honored
The Mayo Clinic and Ivy Foundation
A Message from Catherine Ivy
The Ivy Foundation has the long-term, ultimate goal to cure brain cancer. To that end, we fund cutting-edge research that will improve diagnostics and treatment options for patients with brain cancer. Since 2005, we’ve committed more than $91 million to brain tumor research, with the expectation that this will lead to an eventual cure. We are dedicated to this effort because funding leads to answers, and answers lead to hope.